|Articles|October 31, 2014
Medidata Selected by ASLAN Pharmaceuticals
Medidata announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals
Advertisement
Medidata, a global provider of cloud-based solutions for clinical research in life sciences, announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals, an oncology-focused biotechnology company. ASLAN’s will be using the Medidata Clinical Cloud™ to support the company’s strategy of maximizing the value of its in-licensed drug portfolio by conducting clinical development in Asia.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Moving Beyond Historical Site Data to Real-Time Patient Insight
2
The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior License Execution Would Significantly Benefit Clinical Trial Set-Up
3
Why Trial Competition Is Undermining AI-Driven Gains
4
ACT Brief: Trial Competition Slows AI Gains, Rethinking Patient-Level Safety Decisions, and What Separates Real AI Platforms in Clinical Trials
5